+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Therapeutic Plasma Exchange Market Research Report by Technology (Centrifugation and Membrane Separation), Indication, Product, End-user, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 245 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5147996
UP TO OFF until Mar 31st 2023
The Global Therapeutic Plasma Exchange Market size was estimated at USD 710.47 million in 2022, USD 792.04 million in 2023, and is projected to grow at a CAGR of 10.02% to reach USD 1,525.84 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Therapeutic Plasma Exchange Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Therapeutic Plasma Exchange Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Therapeutic Plasma Exchange Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Therapeutic Plasma Exchange Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Therapeutic Plasma Exchange Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market is studied across Centrifugation and Membrane Separation.
  • Based on Indication, the market is studied across Hematologic Disorders, Metabolic Disorders, Neurological Disorders, and Renal Disorders. The Hematologic Disorders is is further studied across Atypical Hemolytic Uremic Syndrome, Hyperviscosity Syndrome, Severe/Symptomatic Cryoglobulinemia, and Thrombotic Thrombocytopenic Purpura. The Neurological Disorders is is further studied across Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barré Syndrome, Multiple Sclerosis, Myasthenia Gravis, and PANDAS. The Renal Disorders is is further studied across Antibody-mediated Renal Transplant Rejection, Goodpasture Syndrome, and Wegener's Granulomatosis.
  • Based on Product, the market is studied across Consumables and Devices.
  • Based on End-user, the market is studied across Blood Collection Centers & Blood Component Providers and Hospitals & Transfusion Centers.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across Alaska, California, Florida, Illinois, Massachusetts, Michigan, Montana, Nevada, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Therapeutic Plasma Exchange Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Therapeutic Plasma Exchange Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Therapeutic Plasma Exchange Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Therapeutic Plasma Exchange Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Therapeutic Plasma Exchange Market, including Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., Cerus Corporation, Charles River Laboratories International, Inc., Fresenius Medical Care AG & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Infomed SA, Kaneka Corporation, Medica S.P.A., Medicap Clinic GmbH, MEISE Medizintechnik GmbH, Miltenyi Biotec, Nikkiso Co., Ltd., Pall Corporation, Qingdao Haier Biomedical Co., Ltd, Sb-Kawasumi Laboratories, Inc., and Terumo BCT, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Therapeutic Plasma Exchange Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Therapeutic Plasma Exchange Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Therapeutic Plasma Exchange Market?
4. What is the competitive strategic window for opportunities in the Global Therapeutic Plasma Exchange Market?
5. What are the technology trends and regulatory frameworks in the Global Therapeutic Plasma Exchange Market?
6. What is the market share of the leading vendors in the Global Therapeutic Plasma Exchange Market?
7. What modes and strategic moves are considered suitable for entering the Global Therapeutic Plasma Exchange Market?
Frequently Asked Questions about the Global Therapeutic Plasma Exchange Market

What is the estimated value of the Global Therapeutic Plasma Exchange Market?

The Global Therapeutic Plasma Exchange Market was estimated to be valued at $710.47 Million in 2022.

What is the growth rate of the Global Therapeutic Plasma Exchange Market?

The growth rate of the Global Therapeutic Plasma Exchange Market is 10.0%, with an estimated value of $1525.84 Million by 2030.

What is the forecasted size of the Global Therapeutic Plasma Exchange Market?

The Global Therapeutic Plasma Exchange Market is estimated to be worth $1525.84 Million by 2030.

Who are the key companies in the Global Therapeutic Plasma Exchange Market?

Key companies in the Global Therapeutic Plasma Exchange Market include Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., Cerus Corporation, Charles River Laboratories International, Inc., Fresenius Medical Care AG & Co. KGaA, Grifols, S.A., Haemonetics Corporation and Kaneka Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need of Therapeutic Plasma Exchange due to Rise in Prevalence of Autoimmune and Cardiac Diseases
5.1.1.2. Technical Advancement in Apheresis Technologies
5.1.2. Restraints
5.1.2.1. Cost Associated with the Devices and Therapeutic Plasma Exchange Procedures
5.1.3. Opportunities
5.1.3.1. Advancement in Therapeutic Plasma Exchange Technology and its Immunomodulatory Effect in Neuromuscular Diseases
5.1.3.2. Surge in Demand for Therapeutic Plasma Exchange (TPE) in Pediatric Intensive Care
5.1.4. Challenges
5.1.4.1. Complications Associated with the Apheresis Procedure in TPE
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Therapeutic Plasma Exchange Market, by Technology
6.1. Introduction
6.2. Centrifugation
6.3. Membrane Separation

7. Therapeutic Plasma Exchange Market, by Indication
7.1. Introduction
7.2. Hematologic Disorders
7.3.1. Atypical Hemolytic Uremic Syndrome
7.3.2. Hyperviscosity Syndrome
7.3.3. Severe/Symptomatic Cryoglobulinemia
7.3.4. Thrombotic Thrombocytopenic Purpura
7.3. Metabolic Disorders
7.4. Neurological Disorders
7.5.1. Chronic Inflammatory Demyelinating Polyneuropathy
7.5.2. Guillain-Barré Syndrome
7.5.3. Multiple Sclerosis
7.5.4. Myasthenia Gravis
7.5.5. PANDAS
7.5. Renal Disorders
7.6.1. Antibody-mediated Renal Transplant Rejection
7.6.2. Goodpasture Syndrome
7.6.3. Wegener's Granulomatosis

8. Therapeutic Plasma Exchange Market, by Product
8.1. Introduction
8.2. Consumables
8.3. Devices

9. Therapeutic Plasma Exchange Market, by End-user
9.1. Introduction
9.2. Blood Collection Centers & Blood Component Providers
9.3. Hospitals & Transfusion Centers

10. Americas Therapeutic Plasma Exchange Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Therapeutic Plasma Exchange Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Therapeutic Plasma Exchange Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Product Portfolio Analysis, By Key Player
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Asahi Kasei Medical Co., Ltd.
14.2. B. Braun Melsungen AG
14.3. Baxter International Inc.
14.4. Cerus Corporation
14.5. Charles River Laboratories International, Inc.
14.6. Fresenius Medical Care AG & Co. KGaA
14.7. Grifols, S.A.
14.8. Haemonetics Corporation
14.9. Infomed SA
14.10. Kaneka Corporation
14.11. Medica S.P.A.
14.12. Medicap Clinic GmbH
14.13. MEISE Medizintechnik GmbH
14.14. Miltenyi Biotec
14.15. Nikkiso Co., Ltd.
14.16. Pall Corporation
14.17. Qingdao Haier Biomedical Co., Ltd
14.18. Sb-Kawasumi Laboratories, Inc.
14.19. Terumo BCT, Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET DYNAMICS
FIGURE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, 2018-2030 (USD THOUSAND)
FIGURE 16. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, 2018-2030 (USD THOUSAND)
FIGURE 17. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 18. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 19. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2030
FIGURE 20. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD THOUSAND)
FIGURE 21. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, 2018-2030 (USD THOUSAND)
FIGURE 22. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, 2018-2030 (USD THOUSAND)
FIGURE 23. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, 2018-2030 (USD THOUSAND)
FIGURE 24. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, 2018-2030 (USD THOUSAND)
FIGURE 25. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD THOUSAND)
FIGURE 26. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD THOUSAND)
FIGURE 27. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, 2018-2030 (USD THOUSAND)
FIGURE 28. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, 2018-2030 (USD THOUSAND)
FIGURE 29. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD THOUSAND)
FIGURE 30. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, 2018-2030 (USD THOUSAND)
FIGURE 31. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, 2018-2030 (USD THOUSAND)
FIGURE 32. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD THOUSAND)
FIGURE 33. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, 2018-2030 (USD THOUSAND)
FIGURE 34. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, 2018-2030 (USD THOUSAND)
FIGURE 35. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, 2018-2030 (USD THOUSAND)
FIGURE 36. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 37. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 38. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 39. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD THOUSAND)
FIGURE 40. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
FIGURE 41. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 42. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 43. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 44. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, 2018-2030 (USD THOUSAND)
FIGURE 45. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, 2018-2030 (USD THOUSAND)
FIGURE 46. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 47. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 48. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 49. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 50. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 51. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 52. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 53. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 54. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 55. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 56. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 57. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 58. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 59. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 60. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 61. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 62. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 63. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 64. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 65. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 66. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 67. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 68. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 69. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 70. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 71. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 72. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 73. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 75. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 76. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 78. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 79. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 80. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 81. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 82. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 83. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 84. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 85. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 86. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 87. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 88. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 89. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 90. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 91. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 92. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 93. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 94. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 95. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 96. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 97. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 98. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 99. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 100. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 101. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, 2018-2030 (USD THOUSAND)
TABLE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, 2018-2030 (USD THOUSAND)
TABLE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD THOUSAND)
TABLE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 16. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 17. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, 2018-2030 (USD THOUSAND)
TABLE 18. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 19. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 20. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, 2018-2030 (USD THOUSAND)
TABLE 21. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 22. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 23. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, 2018-2030 (USD THOUSAND)
TABLE 24. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 25. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 26. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, 2018-2030 (USD THOUSAND)
TABLE 27. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 28. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 29. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD THOUSAND)
TABLE 30. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 31. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 32. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD THOUSAND)
TABLE 33. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 34. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 35. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, 2018-2030 (USD THOUSAND)
TABLE 36. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 37. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 38. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, 2018-2030 (USD THOUSAND)
TABLE 39. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 40. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 41. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD THOUSAND)
TABLE 42. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 43. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 44. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, 2018-2030 (USD THOUSAND)
TABLE 45. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 46. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 47. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, 2018-2030 (USD THOUSAND)
TABLE 48. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 49. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 50. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD THOUSAND)
TABLE 51. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 52. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 53. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, 2018-2030 (USD THOUSAND)
TABLE 54. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 55. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 56. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, 2018-2030 (USD THOUSAND)
TABLE 57. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 58. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 59. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, 2018-2030 (USD THOUSAND)
TABLE 60. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 61. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 62. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 63. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD THOUSAND)
TABLE 64. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 65. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 66. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
TABLE 67. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 68. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 69. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 70. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, 2018-2030 (USD THOUSAND)
TABLE 71. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 72. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 73. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, 2018-2030 (USD THOUSAND)
TABLE 74. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 75. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 76. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 77. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 78. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 79. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 80. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 81. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 82. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 83. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 84. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 85. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 86. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 87. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 88. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 89. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 90. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 91. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 92. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 93. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 94. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 95. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 96. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 97. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 98. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 99. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 100. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 101. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 102. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 103. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
TABLE 104. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 105. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 106. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 107. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 108. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 109. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 110. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 111. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 112. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 113. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 114. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 115. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 116. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 117. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 118. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 119. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 120. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 121. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 122. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 123. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 124. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 125. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 126. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 127. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 128. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 129. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 130. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 131. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 132. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 133. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 134. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 135. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 136. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 137. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 138. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 139. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 140. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 141. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 142. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 143. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 144. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 145. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 146. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 147. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 148. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 149. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 150. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 151. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 152. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 153. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 154. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 155. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 156. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 157. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 158. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 159. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 160. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 161. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 162. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 163. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 164. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 165. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 166. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 167. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 168. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 169. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 170. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 171. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 172. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 173. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 180. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 181. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 182. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 183. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 184. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 185. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 186. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 187. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 188. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 189. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 190. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 191. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 192. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 193. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 194. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 195. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 196. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 197. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 198. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 199. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 200. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 201. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 202. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 203. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 204. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 205. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 206. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 207. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 208. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 209. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 210. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 211. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 212. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 213. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 214. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 215. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 216. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 217. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 218. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 219. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 220. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 221. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 222. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 223. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 224. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 225. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 226. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 227. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 228. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 229. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 230. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 231. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 232. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 233. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 234. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 235. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 236. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 237. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 238. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 239. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 240. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 241. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 242. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 243. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 244. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 245. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 246. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 247. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 248. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 249. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 250. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 251. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 252. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 253. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 254. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 255. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 256. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 257. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 258. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 259. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 260. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 261. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 262. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 263. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 264. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 265. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 266. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 267. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 268. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 269. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 270. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 271. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 272. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 273. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 274. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 275. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 276. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 277. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 278. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 279. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 280. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 281. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 282. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD THOUSAND)
TABLE 283. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 284. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 285. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 286. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 287. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 288. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET RANKING, BY KEY PLAYER, 2022
TABLE 289. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 290. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 291. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET MERGER & ACQUISITION
TABLE 292. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 293. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 294. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET INVESTMENT & FUNDING
TABLE 295. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 296. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: LICENSE & PRICING

Companies Mentioned

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cerus Corporation
  • Charles River Laboratories International, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Grifols, S.A.
  • Haemonetics Corporation
  • Infomed SA
  • Kaneka Corporation
  • Medica S.P.A.
  • Medicap Clinic GmbH
  • MEISE Medizintechnik GmbH
  • Miltenyi Biotec
  • Nikkiso Co., Ltd.
  • Pall Corporation
  • Qingdao Haier Biomedical Co., Ltd
  • Sb-Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

Methodology

Loading
LOADING...